Regeneron Pharmaceuticals Logo

Regeneron Pharmaceuticals

🇺🇸
REGN
US75886F1075

Regeneron Pharmaceuticals is a leading US-based biopharmaceutical company that researches, develops, and markets innovative medicines. It focuses on improving the health of patients with serious diseases through scientific discoveries in areas such as oncology, immunology, and ophthalmology.

Next Quarterly Earnings

Thursday, July 30, 2026
CW 31
Pre-Market
In 25 days

Stock Price

All Dates

Company Information

Name
Regeneron Pharmaceuticals
Ticker Symbol
REGN
ISIN
US75886F1075
Country
🇺🇸
USA